The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

6 Jul 2020 07:00

RNS Number : 0478S
Sabien Technology Group PLC
06 July 2020
 

6 July 2020

Sabien Technology Group plc

("Sabien" or the "Company")

Trading Update

The Covid-19 pandemic has affected the entire global economy and Sabien has not escaped its impact. However, in spite of this unprecedented disruption, Sabien's revenues doubled in the second half of the financial year compared to the first half. This brings total sales (unaudited) for the year to approximately £460,000 (FY19: £1,379,000). The decrease in full year sales, while disappointing, is explained by last year's revenues including an exceptional order of £846,375 and by three months of lost sales due to the Covid lockdown in this period.

However, the Board believes that first half sales represent a "low watermark" after several years of diminishing performance by the previous Board and management team. Since the new management team has taken charge earlier this year, sales prospects are demonstrably strengthening, and consistent year-on-year growth is expected as the Company transitions into a more realisable go-to market strategy based on an enhanced product and service proposition.

In addition, the Board has sought to protect shareholder value in challenging market conditions by placing a focus on cash management. During the year cash in the bank has increased to £777,848 at 30 June 2020 (30 June 2019: £738,000; 30 June 2018: £9,000). This includes a Covid business interruption loan of £181,000 from NatWest Bank received on 25 June.

While Covid uncertainty has made it impossible to achieve a profitable performance this year, costs have been tightly controlled within the operating business as follows:

· Following, the announcement of major new strategic shareholder on 3 September 2019, the management team has been restructured with the departure of the Alan O'Brien, CEO, (announced 5/11/19) and David Bakst, Managing Director (announced (29/5/20). Until further notice these functions will filled by Executive Chairman, Richard Parris. These changes will contribute an annual saving on the operating company payroll of more than £200,000 from 1 June 2020.

· The Board placed 85% of the workforce on Covid-19 furlough from 31 March 2020. This has mitigated payroll expenses for 25% of the financial year and has helped to preserve jobs and expertise. During this period the Company was unable gain access to customer sites to undertake any installations but background sales and planning tasks to have been undertaken to the extent possible using non-furloughed staff.

The Company has recently started a development project to "cloud enable" its existing M2G user base (up to circa 10,500 units). This will enable upselling opportunities to existing customers and provide a source of new subscription revenue within the next period. For the first time in the Company's history this will enable recurring revenues to be generated from its large installed base. It is anticipated this will also reduce the time to secure new orders and support an international channel partner programme. Early revenues from this new Cloud service are expected before the end of 2020.

Operationally, Sabien is planning a strong start to the new financial period with a backlog of more than 300 M2G units to install and a confirmed order book of approximately £140,000. Commencing 16 June 2020, staff are being phased back from furlough leave to enable the Company to start to install backlogged units. The limiting factor is regaining access to customer sites which have been in lockdown since March. It is likely that full operations will restored within 3 months, with a new look business focused increasingly on indirect selling through channel partners in the UK and the US.

Richard Parris, Chairman, said: "The Sabien operating business is entering the new financial year in good shape to deliver year-on-year growth, relative to FY2020. This is a direct result of the Board's restructuring of the management and sales teams. During FY2021 and beyond we are expecting a sales bounce from (1) a post-Covid investment focus on green technology and (2) recessionary sentiments across the economy that will place a immediate customer emphasis on cost reduction programmes with short payback windows. I believe Sabien is now well placed to benefit from both of these macro trends and, in conjunction with our cost control measures, the Company is in a strong position for a return to profitability. The Board thanks Sabien staff for their support and forbearance during the difficult time of furlough and we look forward to welcoming you back over the coming weeks."

 

For further information:

Sabien Technology Group plc

Richard Parris, Chairman

SPARK Advisory Partners Limited (Nominated Adviser)

Neil Baldwin / Matt Davis

Peterhouse Capital Limited (Broker)

Duncan Vasey/ Lucy Williams 

+44 20 7993 3700

 

+44 203 368 3550 

 

+44 207 469 0930

A copy of this announcement will be available from the Company's website at www.sabien-tech.co.uk

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTKKNBQABKDNOK
Date   Source Headline
28th Mar 20242:30 pmRNSDirector/PDMR Shareholding
8th Mar 20247:00 amRNSHolding(s) in Company
6th Mar 20247:00 amRNSHolding(s) in Company
5th Mar 202411:52 amRNSHolding(s) in Company
29th Feb 20245:00 pmRNSTotal Voting Rights
21st Feb 202411:27 amRNSResult of Broker Option, Issue of Equity and TVR
20th Feb 20243:45 pmRNSDirector/PDMR Shareholding
19th Feb 20247:45 amRNSPlacement and Broker Option
19th Feb 20247:30 amRNSHalf-year Report for the 6 months to 31 Dec 2023
7th Feb 20247:00 amRNSNew system installed at Hampton Court Palace
9th Jan 20247:00 amRNSTrading Update
29th Nov 20231:00 pmRNSResult of AGM
29th Nov 20237:30 amRNSAGM Statement
21st Nov 20231:30 pmRNSHolding(s) in Company
3rd Nov 20234:50 pmRNSHolding(s) in Company
2nd Nov 20231:34 pmRNSHolding(s) in Company
2nd Nov 20237:00 amRNSFinal Results & Annual Report & Accounts for 2023
1st Nov 20237:15 amRNSUpdate on 2023 Audited Accounts
4th Oct 20237:00 amRNSM2G Rollout in US
26th Sep 20237:00 amRNSProton Technologies
22nd Sep 20236:00 pmRNSHolding(s) in Company
6th Jul 20237:00 amRNSTrading Update
8th Jun 20237:00 amRNSM2G Business Update
16th May 20237:00 amRNSFurther update on b.grn and related matters
17th Apr 20237:00 amRNSUpdate on b.grn
13th Apr 20239:15 amRNSHolding(s) in Company
6th Apr 20237:00 amRNSDirector/PCA Shareholding
5th Apr 20235:00 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSInterim Results for the 6 months to 31 Dec 2022
28th Mar 20237:00 amRNSMaterial M2G Order & Business Update
27th Mar 20237:00 amRNSM2G supports Empiric on net zero goals
10th Mar 202311:33 amRNSHolding(s) in Company
10th Mar 202311:30 amRNSHolding(s) in Company
10th Mar 20237:00 amRNSMaterial M2G order and M2G trading update
28th Feb 20232:45 pmRNSHolding(s) in Company
6th Feb 20234:30 pmRNSHolding(s) in Company
2nd Feb 20234:51 pmRNSHolding(s) in Company
22nd Nov 202212:00 pmRNSResult of AGM
22nd Nov 20227:30 amRNSInvestor Update & Annual General Meeting Statement
18th Nov 20221:46 pmRNSHolding(s) in Company
10th Nov 20227:00 amRNSInvestor Update Presentation
2nd Nov 20227:00 amRNSSupply of UK's First Regenerative Green Oil System
24th Oct 20227:00 amRNSOrder Update – New Channel Partner & Customer
17th Oct 20222:47 pmRNSHoling(s) in Company
17th Oct 20221:54 pmRNSHolding(s) in Company
17th Oct 20227:00 amRNSInternational Environmental Trae Summit Upate
17th Oct 20227:00 amRNSHoling(s) in Company
17th Oct 20227:00 amRNSInternational Environmental Trade Summit Update
17th Oct 20227:00 amRNSHolding(s) in Company
14th Oct 20227:00 amRNSFinal Results for the Year to 30 June 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.